OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.

doi:10.1016/j.gene.2018.01.100

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.

Gene - 20 Apr 2018

Li Xiao-Ping, Lan Jian-Yun, Liu Dong-Qin, Zhou Hang, Qian Miao-Miao, Wang Wei-Wei, Yang Man

Abstract excerpt

BACKGROUND: Genome-wide association study (GWAS) studies have showed that single nucleotide polymorphisms (SNPs) in OCA2 gene were associated with the survival of breast cancer patients treated with adjuvant chemotherapy. To further explain the association between OCA2 SNPs and breast cancer survival, we investigated the predictive value of rs4778137 located in OCA2 in local advanced breast cancer patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Combined Modality Therapy

Share to Epirubicin

Share to Membrane Transport Proteins

Share to Neoadjuvant Therapy

Share to Survival Analysis

Share to Taxoids

Source

Open in PubMed

Identifiers

PMID: 29409738
DOI: 10.1016/j.gene.2018.01.100

Genes

OCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.PMID 29409738Read ↗

Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.Semantic proximity Read ↗

Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.Semantic proximity Read ↗

Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.Semantic proximity Read ↗

Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis.Semantic proximity Read ↗

Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.Semantic proximity Read ↗

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.Semantic proximity Read ↗

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer.Semantic proximity Read ↗

Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients.Semantic proximity Read ↗

A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.Semantic proximity Read ↗

SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.